Are you Dr. Fingert?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 30 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
115 Waban Hill Rd N
Chestnut Hill, MA 02467Phone+1 860-732-2776
Summary
- Dr. Howard Fingert, MD is an oncologist in Chestnut Hill, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1980 - 1984
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1977 - 1979
University of Illinois College of MedicineClass of 1977
Certifications & Licensure
MA State Medical License 1980 - 2019
Publications & Presentations
PubMed
- 165 citationsIn Vitro Evidence That Myocardial Ischemia Resulting from 5-Fluorouracil Chemotherapy Is Due to Protein Kinase C-mediated Vasoconstriction of Vascular Smooth MuscleMorris Mosseri, Howard J. Fingert, Lyuba Varticovski, Saurabh K. Chokshi, Jeffrey M. Isner
Cancer Research. 1993-07-01 - 133 citationsPhase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral FormulationsE. Claire Dees, Roger B. Cohen, Margaret von Mehren, Thomas E. Stinchcombe, Hua Liu
Clinical Cancer Research. 2012-09-01 - 62 citationsPhase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumorsE. Claire Dees, Jeffrey R. Infante, Roger B. Cohen, Bert H. O'Neil, Suzanne F. Jones
Cancer Chemotherapy and Pharmacology. 2011-04-01
